mRNA vaccines: The future of prevention of viral infections?
P Rzymski, A Szuster‐Ciesielska… - Journal of medical …, 2023 - Wiley Online Library
Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …
preparations developed using this platform. During the pandemic, their administration has …
mRNA vaccines against respiratory viruses
JA Whitaker, HM El Sahly… - Current Opinion in …, 2023 - journals.lww.com
mRNA vaccines against respiratory viruses : Current Opinion in Infectious Diseases mRNA
vaccines against respiratory viruses : Current Opinion in Infectious Diseases Log in or Register …
vaccines against respiratory viruses : Current Opinion in Infectious Diseases Log in or Register …
[HTML][HTML] Effectiveness of monovalent and bivalent mRNA vaccines in preventing COVID-19–associated emergency department and urgent care encounters among …
R Link-Gelles - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
Abstract On June 19, 2022, the original monovalent mRNA COVID-19 vaccines were
approved as a primary series for children aged 6 months–4 years (Pfizer-BioNTech) and 6 …
approved as a primary series for children aged 6 months–4 years (Pfizer-BioNTech) and 6 …
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
F Zhu, S Huang, X Liu, Q Chen, C Zhuang… - The Lancet …, 2023 - thelancet.com
Background The live-attenuated influenza virus vector-based intranasal SARS-CoV-2
vaccine (dNS1-RBD, Pneucolin; Beijing Wantai Biological Pharmacy Enterprise, Beijing …
vaccine (dNS1-RBD, Pneucolin; Beijing Wantai Biological Pharmacy Enterprise, Beijing …
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases
LR Baden, HM El Sahly, B Essink, D Follmann… - Nature …, 2024 - nature.com
Abstract Primary vaccination with mRNA-1273 (100-µg) was safe and efficacious at
preventing coronavirus disease 2019 (COVID-19) in the previously reported, blinded Part A …
preventing coronavirus disease 2019 (COVID-19) in the previously reported, blinded Part A …
Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization
Infants are at a higher risk of Coronavirus Disease 2019 (COVID-19)-related hospitalizations
compared to older children. In this study, we investigated the effect of the recommended …
compared to older children. In this study, we investigated the effect of the recommended …
[HTML][HTML] Preliminary estimates of effectiveness of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection among children aged 3–5 years …
KE Fleming-Dutra - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
Since June 2022, COVID-19 primary series vaccination has been recommended for young
children with either Moderna for children aged 6 months–5 years or Pfizer-BioNTech for …
children with either Moderna for children aged 6 months–5 years or Pfizer-BioNTech for …
Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice
In response to the human Mpox (hMPX) epidemic that began in 2022, there is an urgent
need for a monkeypox vaccine. Here, we have developed a series of mRNA-lipid …
need for a monkeypox vaccine. Here, we have developed a series of mRNA-lipid …
[HTML][HTML] Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA …
Background Data on the protection conferred by COVID-19 vaccination and previous SARS-
CoV-2 infection against omicron (B. 1.1. 529) infection in young children are scarce. We …
CoV-2 infection against omicron (B. 1.1. 529) infection in young children are scarce. We …
Emerging and re-emerging pediatric viral diseases: a continuing global challenge
SA Hoffman, YA Maldonado - Pediatric Research, 2024 - nature.com
The twenty-first century has been marked by a surge in viral epidemics and pandemics,
highlighting the global health challenge posed by emerging and re-emerging pediatric viral …
highlighting the global health challenge posed by emerging and re-emerging pediatric viral …